Keystone Investors PTE Ltd. reduced its holdings in Relx Plc (NYSE:RELX - Free Report) by 83.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 5,617 shares of the technology company's stock after selling 28,433 shares during the quarter. Keystone Investors PTE Ltd.'s holdings in Relx were worth $255,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Private Trust Co. NA grew its stake in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the last quarter. Sage Mountain Advisors LLC grew its position in shares of Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after acquiring an additional 258 shares during the last quarter. Peapack Gladstone Financial Corp increased its holdings in shares of Relx by 5.7% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company's stock worth $234,000 after acquiring an additional 267 shares during the period. EWA LLC lifted its position in Relx by 5.2% in the 3rd quarter. EWA LLC now owns 5,501 shares of the technology company's stock valued at $253,000 after purchasing an additional 272 shares during the last quarter. Finally, Marks Group Wealth Management Inc boosted its stake in Relx by 1.3% during the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company's stock valued at $1,190,000 after purchasing an additional 325 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on RELX shares. Barclays upgraded Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. StockNews.com cut Relx from a "buy" rating to a "hold" rating in a research note on Tuesday, March 4th. The Goldman Sachs Group started coverage on shares of Relx in a research note on Wednesday. They set a "buy" rating on the stock. Finally, Redburn Atlantic started coverage on shares of Relx in a research report on Wednesday, January 8th. They set a "buy" rating on the stock. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy".
Read Our Latest Stock Report on RELX
Relx Price Performance
Shares of Relx stock traded up $0.14 during trading on Friday, hitting $50.21. The stock had a trading volume of 560,996 shares, compared to its average volume of 757,401. The business has a fifty day moving average of $49.48 and a two-hundred day moving average of $47.82. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The firm has a market cap of $93.18 billion, a P/E ratio of 26.99, a PEG ratio of 2.73 and a beta of 0.90. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47.
Relx Increases Dividend
The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be issued a $0.5586 dividend. This represents a yield of 1.6%. This is an increase from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. Relx's dividend payout ratio is presently 59.68%.
Relx Profile
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading
Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
